Rigel Pharmaceuticals
RIGL
#7137
Rank
NZ$0.82 B
Marketcap
NZ$44.93
Share price
-2.44%
Change (1 day)
28.69%
Change (1 year)

Rigel Pharmaceuticals (RIGL) Fails to deliver data

Key failure to deliver metrics for Rigel Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Rigel Pharmaceuticals (RIGL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Rigel Pharmaceuticals (RIGL) - since 2024

Volume in USD (price x number of shares), data since 2024

Rigel Pharmaceuticals (RIGL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$1.09 M43.6%
2025NZ$0.76 M30.36%
2024NZ$0.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
NZ$0.21 BNZ$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$0.12 BNZ$0.19 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$0.51 MNZ$8.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
NZ$0.23 MNZ$0.23 M๐Ÿ‡บ๐Ÿ‡ธ USA